AzTrials
AzTrials

Healthy Older AdultsIRENCT04353947

Induction and Recognition of Emotions

An observational study of Healthy Older Adults and Alzheimer's Disease, run by University of Valencia at 1 site in Spain.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study evaluates the differences in cognitive function between healthy older adults, older adults with mild Alzheimer's type dementia and older adults with Parkinson's disease and if there are differences in valence assessment and activation that produce them a mood induction task. Read more about this study

Who is it for?
Ages 65 to 99 yearsHealthy volunteers can take part
What is being tested?
Mini Cognitive Examination (MCE), Beck Depression Inventory-II (BDI-II) and Global Deterioration Scale (GDS)
How many people
0 participants
Where
1 siteSpain
Study dates
2 Mar 2020to 30 Nov 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: * Healthy older adults will be recruited from the Third Age Classrooms of the municipality of Quart de Poblet. * The older adults with mild Alzheimer's disease will be recruited through the Neurology Department of the General Hospital of Valencia. * The older adults with Parkinson's disease will be recruited through the Valencia Parkinson Association.

Who may be able to join

  • For the group of healthy older adults:
  • MEC score greater than 26 points.
  • GDS between 1 and 3.
  • For the mild EA group:
  • MEC score between 18 and 23 points.
  • GDS between 3 and 4.
Show all 17Show fewer
  • For the EP group:
  • MEC score greater than 23 points.
  • GDS between 1 and 3.
  • FAB score equal to or less than 11 points.
  • General Exclusion Criteria:
  • Participants cannot have:
  • Significant asymptomatic neurovascular disease
  • History of previous symptomatic stroke
  • Alcohol or drug abuse/dependence
  • Severe psychiatric symptoms
  • Depressive symptoms higher than mild

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • University of Valencia

    Valencia, 46010

Other trials in Spain

About this study

Official title: Induction and Recognition of Emotions in Healthy Older Adults, Alzheimer's Disease and Parkinson's Disease

This study evaluates the differences in cognitive function between healthy older adults, older adults with mild Alzheimer's type dementia and older adults with Parkinson's disease and if there are differences in valence assessment and activation that produce them a mood induction task. Subjects are assessed using neuropsychological tests and then a mood induction task based on movie clips is applied.

Read the detailed description

Different neuropsychological tests will be used to assess the differences in cognitive function in the different groups, whose scores are expected to be lower in the group of older adults with Alzheimer's disease (AD) and older adults with Parkinson's disease (PD).

After studying the cognitive function in the different groups, we proceed to check through a task based on movie clips if there are also differences in the valence assessment (liking/disliking depending on the emotion induced by scenes from different films) and activation (excitement caused by each one of the movie scenes), hoping to find differences for the negative emotions taking into account the cognitive difficulties that both (the EA group and the EP group) may have for processing this type of cognitively more demanding information; instead, it is possible that the positivity effect continues to affect these patients so that for positive emotions there are no differences between the different groups.

Being tested
Mini Cognitive Examination (MCE), Beck Depression Inventory-II (BDI-II), Global Deterioration Scale (GDS), Memory alteration test (M@T), Spanish-Complutense Verbal Learning Test (TAVEC)
Keywords
Healthy older adults, Alzheimer's disease, Parkinson's disease, Mood induction, Positive emotions, Negative emotions
Medical subject headings
Alzheimer Disease, Parkinson Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mini Cognitive Examination (MCE)Diagnostic test

    This test provides information on temporal and spatial orientation, fixation, concentration and calculation, memory and language and construction.

  • Beck Depression Inventory-II (BDI-II)Diagnostic test

    This test evaluates the absence or presence of depressive symptoms.

  • Global Deterioration Scale (GDS)Diagnostic test

    This scale measures the level of deterioration of the subject.

  • Memory alteration test (M@T)Diagnostic test

    In this test different memory subtypes are evaluated.

  • Spanish-Complutense Verbal Learning Test (TAVEC)Diagnostic test

    This test is used to assess immediate memory, deferred memory and learning ability.

  • Barcelona test (BT)Diagnostic test

    This test evaluates categorical evocation and verbal fluency. The categorical recall subtest consists of recalling the maximum number of words linked to a specific category "animals" in 1 minute. In the case of verbal fluency, the subject is asked to evoke the maximum number of words that begin with the letter "p" in 3 minutes.

  • Rey-Osterrieth Complex Figure Test (ROCFT)Diagnostic test

    In this test, the person must carefully copy a complex geometric drawing, which must be memorized later. The first part evaluates multiple cognitive processes such as planning, motor skills, working memory, and visual-constructive and spatial skills. In the second part, memory is evaluated.

  • Frontal assessment battery (FAB)Diagnostic test

    This test is a composite tool for assessing executive functions related to the frontal lobe.

  • Positive and Negative Affect Scale (PANAS)Diagnostic test

    It is a self-report questionnaire made up of 20 items (10 of positive affect and another 10 of negative affect) that the subject must answer, obtaining in this way a score in positive affectivity (AP subscale) and another in negative affectivity (AN subscale).

  • Auto-Assessment Manikins (SAM)Diagnostic test

    It is a self-report questionnaire that assesses the emotional response of the subject, in this case, through a mood induction task that plays different films scenes.

Study groups in NCT04353947
Study groupRoleWhat they receive
Healthy older adultsHealthy older adults with 65 years or older
Receives: Diagnostic Test: Mini Cognitive Examination (MCE); Diagnostic Test: Beck Depression Inventory-II (BDI-II); Diagnostic Test: Global Deterioration Scale (GDS); Diagnostic Test: Memory alteration test (M@T); Diagnostic Test: Spanish-Complutense Verbal Learning Test (TAVEC); Diagnostic Test: Barcelona test (BT); Diagnostic Test: Rey-Osterrieth Complex Figure Test (ROCFT); Diagnostic Test: Positive and Negative Affect Scale (PANAS); Diagnostic Test: Auto-Assessment Manikins (SAM)
Older adults with Alzheimer's diseaseOlder adults with Alzheimer's disease with 65 years or older
Receives: Diagnostic Test: Mini Cognitive Examination (MCE); Diagnostic Test: Beck Depression Inventory-II (BDI-II); Diagnostic Test: Global Deterioration Scale (GDS); Diagnostic Test: Memory alteration test (M@T); Diagnostic Test: Spanish-Complutense Verbal Learning Test (TAVEC); Diagnostic Test: Barcelona test (BT); Diagnostic Test: Rey-Osterrieth Complex Figure Test (ROCFT); Diagnostic Test: Positive and Negative Affect Scale (PANAS); Diagnostic Test: Auto-Assessment Manikins (SAM)
Older adults with Parkinson's diseaseOlder adults with Alzheimer's disease with 65 years or older
Receives: Diagnostic Test: Mini Cognitive Examination (MCE); Diagnostic Test: Beck Depression Inventory-II (BDI-II); Diagnostic Test: Global Deterioration Scale (GDS); Diagnostic Test: Memory alteration test (M@T); Diagnostic Test: Spanish-Complutense Verbal Learning Test (TAVEC); Diagnostic Test: Barcelona test (BT); Diagnostic Test: Rey-Osterrieth Complex Figure Test (ROCFT); Diagnostic Test: Frontal assessment battery (FAB); Diagnostic Test: Positive and Negative Affect Scale (PANAS); Diagnostic Test: Auto-Assessment Manikins (SAM)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mini-Mental State Examination (MMSE)

    This test is evaluated on a maximum of 30 points. Participants with scores equal to or below 23 would be considered cognitively deficient.

    Measured: 5-10 minutes

  2. Beck Depression Inventory-II (BDI-II)

    In this test, a score of 0-13 indicates absence of depression, 14-19 mild depression, 20-28 moderate depression, and 29-63 severe depression.

    Measured: 5-10 minutes

  3. Global Deterioration Scale (GDS)

    This scale indicates seven possible stages: 1. Absence of Cognitive Deficit; 2. Very slight cognitive deficit; 3. Mild Cognitive Deficit; 4. Moderate cognitive deficit; 5. Moderately severe cognitive deficit; 6. Severe cognitive deficit; 7. Very severe cognitive deficit.

    Measured: 30 minutes

  4. Memory alteration test (M@T)

    This cognitive test is evaluated on a maximum of 50 points. The optimal cut-off point for distinguishing mild cognitive impairment of the amnesiac type from subjective memory complaints is 37 points. The optimal cut-off point for Alzheimer's disease is 31 points.

    Measured: 5-10 minutes

  5. Spanish-Complutense Verbal Learning Test (TAVEC)

    The evaluator reads a 16-word shopping list in five different essays and in each of them the evaluated person must mention those words that he or she remembers. After 20 minutes, the subject is asked to remember them again.

    Measured: 30 minutes

  6. Barcelona test (BT)

    In this test, the subject is considered to have a good categorical evocation when he is able to evoke more than 16 animals in 1 minute and a good verbal fluency when he is able to evoke more than 19 words beginning with "p" in 3 minutes.

    Measured: 5 minutes

  7. Rey-Osterrieth Complex Figure Test (ROCFT)

    The direct score (PD) in the copy of the Rey figure that would leave 50% of the population below is 30 points, while in the reproduction of the Rey figure from memory the PD that would leave 50% below of the population is 21 points.

    Measured: 10 minutes

  8. Frontal assessment battery (FAB)

    The maximum score to be obtained in this test is 18 points. To consider that the subject presents alterations in the frontal lobe and, therefore, altered executive functions, his score must be equal to or less than 11 points.

    Measured: 10 minutes

  9. Positive and Negative Affect Scale (PANAS)

    The final score of this scale is the sum of the 10 terms on the positive scale and the sum of the 10 terms on the negative scale, with the value assigned for the responses on the positive scale being positive and negative for the responses on the negative scale.

    Measured: 10 minutes

  10. Auto-Assessment Manikins (SAM)

    This questionnaire measures the valence (liking/disliking depending on the emotion induced by scenes from different movies), the arousal (excitement caused by each of the movie scenes) and mastery or emotional control (self-perception of the control exerted on the environment and the emotion itself).

    Measured: 5-10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2020
  2. Study start2 Mar 2020
  3. Primary completion30 Oct 2020 (estimated)
  4. Study completion30 Nov 2020 (estimated)

Why it stopped: COVID 19

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04353947
Sponsor's protocol ID
UV-INV_ETICA-1217558
Acronym
IRE
Status last verified
May 2021
First submitted
16 Apr 2020
Last updated
6 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: All the information of the study, as well as its results, will be shared in scientific publications and conferences related to the research area. The information that is intended to be published in scientific journals includes: 1) Study Protocol, 2) Statistical Analysis, 3) Informed Consent Form, 4) Clinical Study Results.

Publications

  • Fernandez-Aguilar L, Ricarte J, Ros L, Latorre JM. Emotional Differences in Young and Older Adults: Films as Mood Induction Procedure. Front Psychol. 2018 Jul 3;9:1110. doi: 10.3389/fpsyg.2018.01110. eCollection 2018.

    PubMed 30018584
  • Carvalho S, Leite J, Galdo-Alvarez S, Goncalves OF. The Emotional Movie Database (EMDB): a self-report and psychophysiological study. Appl Psychophysiol Biofeedback. 2012 Dec;37(4):279-94. doi: 10.1007/s10484-012-9201-6.

    PubMed 22767079
  • Alves H, Koch A, Unkelbach C. Why Good Is More Alike Than Bad: Processing Implications. Trends Cogn Sci. 2017 Feb;21(2):69-79. doi: 10.1016/j.tics.2016.12.006. Epub 2017 Jan 4.

    PubMed 28063663
  • Alves H, Koch A, Unkelbach C. The differential similarity of positive and negative information - an affect-induced processing outcome? Cogn Emot. 2019 Sep;33(6):1224-1238. doi: 10.1080/02699931.2018.1549022. Epub 2018 Nov 26.

    PubMed 30475089
  • Reed AE, Carstensen LL. The theory behind the age-related positivity effect. Front Psychol. 2012 Sep 27;3:339. doi: 10.3389/fpsyg.2012.00339. eCollection 2012.

    PubMed 23060825
  • Nashiro K, Mather M. Effects of emotional arousal on memory binding in normal aging and Alzheimer's disease. Am J Psychol. 2011 Fall;124(3):301-12. doi: 10.5406/amerjpsyc.124.3.0301.

    PubMed 21977692

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy Older Adults and Alzheimer's Disease, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 17 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 6 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mini-Mental State Examination (MMSE) (time frame: 5-10 minutes). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04353947, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in